Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Swaddling and Breast Milk Odor for Stress and Comfort in Late Preterm Babies Receiving High-Flow Breathing Support Through the Nose

10. November 2026 aktualisiert von: Hediye Karakoç, KTO Karatay University

The Effect of the Safe Swaddling Method and the Scent of Breast Milk on Physiological Parameters, Stress, and Comfort Levels in Premature Newborns Receiving Mechanical Ventilator Support: A Randomized Controlled Study

This study compared two approaches to reducing stress and improving comfort in babies born between 34 and 36 completed weeks of pregnancy who were receiving high-flow breathing support through small tubes in the nose.

Seventy-two babies were assigned by chance to one of three groups, with 24 babies in each group. One group was gently swaddled for 20 minutes. A second group was exposed for 20 minutes to the smell of freshly expressed milk from each baby's own mother. The third group received the neonatal intensive care unit's usual care and was observed for 20 minutes.

The study team assessed stress and comfort and recorded heart rate, breathing rate, blood oxygen level, and body temperature at the start of the observation period and again at 5 and 20 minutes. The purpose was to compare how these measures changed over time across the three groups.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Intervention / Behandlung

Studientyp

Interventionell

Einschreibung (Tatsächlich)

72

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Karatay
      • Konya, Karatay, Türkei (türkiye), 42040
        • KTO Karatay University

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

7 Monate bis 8 Monate (Kind)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Gestational age at birth of 34 weeks 0 days to 36 weeks 6 days, inclusive.
  • Within the first 28 days of life at enrollment.
  • Receiving noninvasive respiratory support via a high-flow nasal cannula (HFNC).
  • Birth weight of at least 1,500 g.
  • The infant's mother was able to provide expressed breast milk.
  • No clinical condition that precluded safe positioning or swaddling.
  • Written informed consent obtained from a parent.

Exclusion Criteria:

  • A painful procedure within 1 hour before the start of the planned study session.
  • Receipt of a medication with analgesic or sedative effects within 6 hours before the start of the planned study session.
  • Previous surgery.
  • An active or treatment-requiring clinical condition that could affect physiological measurements or the stress response, such as hypoglycemia, hyperbilirubinemia, or acute infection.
  • Cerebral hypoxia or ischemia.
  • Intraventricular hemorrhage.
  • A major congenital anomaly.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: Zufällig
  • Interventionsmodell: Parallele Zuordnung
  • Maskierung: Single

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Maternal Breast Milk Odor

Infants were exposed for 20 minutes to the odor of freshly expressed breast milk from their own mothers. Ten drops of milk were applied to sterile gauze placed in a sterile container. The container was positioned inside the incubator approximately 1-2 cm from the infant's nose and remained in place throughout the exposure period.

Ten drops of freshly expressed breast milk from each infant's own mother were applied to sterile gauze in a sterile container. The container was placed inside the incubator near the infant's nose for 20 minutes.

Experimental: Safe Swaddling

Infants were positioned supine and swaddled for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The upper limbs were held alongside the trunk in slight flexion. The lower limbs were left free to allow hip flexion and abduction. The cloth was secured loosely enough to permit chest expansion and spontaneous movement.

Infants were swaddled in the supine position for 20 minutes using a thin, breathable muslin cloth measuring 90 × 90 cm. The cloth was secured loosely to allow chest expansion and spontaneous movement, and the lower limbs were left free to permit hip flexion and abduction.

Kein Eingriff: Standard Care

Infants received the neonatal intensive care unit's standard care during a 20-minute observation period. No additional study intervention was administered.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Newborn Stress Scale Total Score Over Time
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Stress was assessed using the Newborn Stress Scale. The scale comprises eight observational domains, each scored from 0 to 2. Total scores range from 0 to 16, with higher scores indicating greater stress. Changes in total scores across the three assessment time points were compared among the study groups.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Premature Infant Comfort Scale Total Score
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Comfort was assessed using the Turkish version of the Premature Infant Comfort Scale. Seven indicators are each scored from 1 to 5. Total scores range from 7 to 35, with lower scores indicating greater comfort.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Heart Rate
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Heart rate was read directly from the bedside monitor and recorded in beats per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Respiratory Rate
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Respiratory rate was read directly from the bedside monitor and recorded in breaths per minute.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Peripheral Oxygen Saturation (SpO₂)
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Peripheral oxygen saturation was read directly from the bedside monitor and recorded as a percentage.

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.
Body Temperature
Zeitfenster: At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Body temperature was read directly from the bedside monitor and recorded in degrees Celsius (°C).

At baseline and at 5 and 20 minutes after the start of the assigned intervention or standard-care observation period.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Hauptermittler: Hediye Karakoç, KTO Karatay Üniversitesi

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

28. Juni 2024

Primärer Abschluss (Tatsächlich)

30. April 2026

Studienabschluss (Tatsächlich)

30. August 2026

Studienanmeldedaten

Zuerst eingereicht

19. August 2025

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

1. Juli 2026

Zuerst gepostet (Tatsächlich)

2. Juli 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

13. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • KARATAYU-SBF-ES-01

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

Security

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .